六块爱理不理 8块高攀不起查看全文
格隆汇11月15日丨Aytu BioPharma(AYTU.US)盘前涨18.76%,报0.23美元。公司2023年Q1财报实现营收2765.5万美元,前值为2189.7万美元,预期值为2430万美元,超出市场预期13.81%;每股收益为-0.06美元,前值为-0.33美元,预期值为-0.18美元,超出市场预期66.67%。 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, item 7.01 Accession Number: 0001654954-20-003829 Act: 34 Size: 30 KB 网页链接
$Aytu BioScience(AYTU)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001213900-20-008577 Act: 33 Size: 191 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001654954-20-003771 Act: 34 Size: 47 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001654954-20-003646 Act: 34 Size: 43 KB 网页链接
$Aytu BioScience(AYTU)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001213900-20-007828 Act: 34 Size: 28 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, item 3.01 Accession Number: 0001654954-20-003132 Act: 34 Size: 29 KB 网页链接
$Aytu BioScience(AYTU)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-20-007140 Act: 34 Size: 62 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001654954-20-002956 Act: 34 Size: 42 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001213900-20-007021 Act: 34 Size: 428 KB 网页链接
$Aytu BioScience(AYTU)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001213900-20-007010 Act: 33 Size: 405 KB 网页链接